ClinicalTrials.gg
Drug

Tinzaparin clinical trials

Also written Innohep.

studies test it
37
open now
6
in phase 3
11
first study started
1993

How each study uses Tinzaparin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tinzaparin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
14 Jul 2000 · INNOHEP · NDA 020484 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tinzaparin
19
Tinzaparin sodium
8
Innohep (Tinzaparin)
2
Tinzaparin (Leo)
2
Tinzaparin Injectable Solution
2

Brand

Innohep
17

Studies by the year they started

37 studies that test it; most in 2005 (5)

Studies that test Tinzaparin, by start year
YearStudies
19931
19941
19971
20022
20032
20042
20055
20071
20091
20101
20112
20132
20151
20161
20181
20201
20213
20224
20232
20242
20261

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
7
Phase 3
11
Phase 4
14
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 35

Ottawa Hospital Research Institute (4) · University of Calgary (3) · LEO Pharma (2) · Assistance Publique - Hôpitaux de Paris (2) · Centre Hospitalier Universitaire, Amiens (1) · University of Melbourne (1) · Alexandra Hospital, Athens, Greece (1) · Galician Research Group on Digestive Tumors (1)

Often tested with

Tested in the same studies.

Dalteparin (7) · Enoxaparin (6) · Rivaroxaban (2) · Apixaban (2) · Nafamostat (1) · Nirmatrelvir (1) · Ritonavir (1) · Remdesivir (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test Tinzaparin.

Studies

Open first, then newest update. How each study uses Tinzaparin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 37

See all 37 studies that test Tinzaparin →

Given beside what is tested · 1 — Tinzaparin is usual care or a partner of the new treatment

Codes

What other systems call Tinzaparin · ClinicalTrials.gg INT006820

  • MeSH (NLM) D000078222TinzaparinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7UQ7X4Y489TINZAPARINConfirmed FDA, NLM, Wikidata
  • RxNorm 69646Confirmed FDA, Wikidata
  • Wikidata Q20817252tinzaparinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C87297TinzaparinOne source FDA
  • DrugBank DB06822One source Wikidata

Also registered as tinzaparin sodium (UNII 3S182ET3UA · RxNorm 104466).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.